Scientists at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) have unveiled MitoCatch, a breakthrough technology designed to deliver healthy mitochondria directly into diseased cells.
Mitochondria- often called the "powerhouses" of cells- are critical for energy production, and their dysfunction is linked to conditions such as Parkinson's disease, optic nerve degeneration, and certain types of heart failure.
Traditional attempts to transplant mitochondria have struggled with efficiency and precision. MitoCatch changes that by using engineered protein "binders" that act like a cellular GPS, guiding donor mitochondria into the right cells. Researchers developed three complementary strategies:
- MitoCatch-C: binders displayed on the cell surface.
- MitoCatch-M: binders attached directly to mitochondria.
- MitoCatch-Bi: bispecific binders linking mitochondria and cell surfaces.
Experiments showed that MitoCatch successfully delivered mitochondria to neurons, retinal cells, heart cells, and immune cells. Once inside, the mitochondria remained functional- moving, fusing, and dividing- all essential processes for healthy energy management. In patient-derived neurons with optic nerve atrophy, donor mitochondria improved survival, while retinal ganglion cells showed recovery after injury. Importantly, animal studies revealed no detectable immune reaction, suggesting the method is well tolerated.
By overcoming the long-standing barrier of cell-specific mitochondrial delivery, MitoCatch represents a potential paradigm shift in treating mitochondrial diseases. It opens the door to precision mitochondrial medicine, where therapies can be tailored to restore energy balance in the cells most affected by disease.
Courtesy: Nature
For comments and feedback contact: editorial@rttnews.com
Health News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.